Cas:175205-64-8 1-[2-(Trifluoromethoxy)phenyl]methanamine manufacturer & supplier

Chemical Name:1-[2-(Trifluoromethoxy)phenyl]methanamine

CAS.NO:175205-64-8

Synonyms:Z1R BOXFFF;1-[2-(Trifluoromethoxy)phenyl]methanamine;2-(Trifluoromethoxy)Benzylamine;(2-(Trifluoromethoxy)phenyl)methanamine;MFCD00085176;2-(Trifluoromethoxy)benzenemethanamine;o-(Trifluoromethoxy)benzylamine;1-[2-Trifluoromethoxy)phenyl]methanamine;Benzenemethanamine, 2-(trifluoromethoxy)-;[2-(trifluoromethoxy)phenyl]methanamine

Molecular Formula:C₈H₈F₃NO

Molecular Weight:191.150

HS Code:2922199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:179.3±35.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.471

PSA:35.25000

Exact Mass:191.055801

LogP:2.04

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN2735

Packing Group:III

Contact us for information like Z1R BOXFFF chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,[2-(trifluoromethoxy)phenyl]methanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzenemethanamine, 2-(trifluoromethoxy)- Use and application,2-(Trifluoromethoxy)Benzylamine technical grade,usp/ep/jp grade.

Related News: The QbD studies were designed concisely to minimize the use of the API and evaluate the critical product parameters that could affect the product quality attributes of the drug product, per FDA’s QbD guidance. [2-((E)-Pent-3-enoylamino)-phenyl]-propynoic acid methyl ester manufacturers Meanwhile, as the government has offered income tax benefits to new entities, Natural Capsules decided to implement the project under its wholly owned subsidiary Natural Biogenex which is dedicated for APIs. 1,2-Benzoxasilepin, 6,7,9-trichloro-2,3,4,5-tetrahydro-2,2-dimethoxy- suppliers As a result, the team identified and prioritized studies that would provide the necessary product and process understanding needed to develop a control strategy, ensure the reproducibility of the product, and meet its intended safety, efficacy, stability, and performance profile regardless of the manufacturing scale. N-(4-methylbenzyl)-6-(morpholinosulfonyl)-2-oxo-1,2-dihydroquinoline-4-carboxamide vendor & factory Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. ,Meanwhile, as the government has offered income tax benefits to new entities, Natural Capsules decided to implement the project under its wholly owned subsidiary Natural Biogenex which is dedicated for APIs.